{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:42:15Z","timestamp":1707525735318},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,27]]},"DOI":"10.7759\/cureus.53055","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T15:18:40Z","timestamp":1706368720000},"source":"Crossref","is-referenced-by-count":0,"title":["Tacrolimus Ointment in Periorbital Atopic Dermatitis"],"prefix":"10.7759","author":[{"given":"Mazen","family":"Alzahrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumna F","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.03.026","article-title":"Periorbital contact sensitization","volume":"150","author":"Landeck L","year":"2010","unstructured":"Landeck L, Schalock PC, Baden LA, Gonzalez E. Periorbital contact sensitization. Am J Ophthalmol. 2010, 150:366-370.e2. 10.1016\/j.ajo.2010.03.026","journal-title":"Am J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(94)70004-4","article-title":"The prevalence of childhood atopic eczema in a general population","volume":"30","author":"Kay J","year":"1994","unstructured":"Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 1994, 30:35-9. 10.1016\/s0190-9622(94)70004-4","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2006.00927.x","article-title":"The aetiology of eyelid dermatitis: a 10-year retrospective analysis","volume":"55","author":"Amin KA","year":"2006","unstructured":"Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis. 2006, 55:280-5. 10.1111\/j.1600-0536.2006.00927.x","journal-title":"Contact Dermatitis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(99)70050-3","article-title":"The clinical spectrum of atopic dermatitis","volume":"104","author":"Beltrani VS","year":"1999","unstructured":"Beltrani VS. The clinical spectrum of atopic dermatitis. J Allergy Clin Immunol. 1999, 104:S87-98. 10.1016\/s0091-6749(99)70050-3","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108647","article-title":"Foundational concepts in the biology of bacterial keratitis","volume":"209","author":"Ung L","year":"2021","unstructured":"Ung L, Chodosh J. Foundational concepts in the biology of bacterial keratitis. Exp Eye Res. 2021, 209:108647. 10.1016\/j.exer.2021.108647","journal-title":"Exp Eye Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease","volume":"135","author":"Rikkers SM","year":"2003","unstructured":"Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol. 2003, 135:297-302. 10.1016\/s0002-9394(02)01982-7","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08192.x","article-title":"A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids","volume":"157","author":"Murrell DF","year":"2007","unstructured":"Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. Br J Dermatol. 2007, 157:954-9. 10.1111\/j.1365-2133.2007.08192.x","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)72027-6","article-title":"Treatment of persistent glaucoma secondary to periocular corticosteroids","volume":"122","author":"Akduman L","year":"1996","unstructured":"Akduman L, Kolker AE, Black DL, Del Priore LV, Kaplan HJ. Treatment of persistent glaucoma secondary to periocular corticosteroids. Am J Ophthalmol. 1996, 122:275-7. 10.1016\/s0002-9394(14)72027-6","journal-title":"Am J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120942","article-title":"Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis","volume":"46","author":"Nghiem P","year":"2002","unstructured":"Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol. 2002, 46:228-41. 10.1067\/mjd.2002.120942","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.574","article-title":"Tacrolimus: the drug for the turn of the millennium?","volume":"135","author":"Ruzicka T","year":"1999","unstructured":"Ruzicka T, Assmann T, Homey B. Tacrolimus: the drug for the turn of the millennium?. Arch Dermatol. 1999, 135:574-80. 10.1001\/archderm.135.5.574","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709183371203","article-title":"A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group","volume":"337","author":"Ruzicka T","year":"1997","unstructured":"Ruzicka T, Bieber T, Sch\u00f6pf E, et al.. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 1997, 337:816-21. 10.1056\/NEJM199709183371203","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00323.x","article-title":"Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial","volume":"111","author":"Reitamo S","year":"1998","unstructured":"Reitamo S, Rissanen J, Remitz A, et al.. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol. 1998, 111:396-8. 10.1046\/j.1523-1747.1998.00323.x","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.172387","article-title":"Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis--case series","volume":"94","author":"Tam PM","year":"2010","unstructured":"Tam PM, Young AL, Cheng LL, Lam PT. Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis--case series. Br J Ophthalmol. 2010, 94:1405-6. 10.1136\/bjo.2009.172387","journal-title":"Br J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi Y","year":"2010","unstructured":"Ohashi Y, Ebihara N, Fujishima H, et al.. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010, 26:165-74. 10.1089\/jop.2009.0087","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2003.11864618","article-title":"Atopic dermatitis management with tacrolimus ointment (Protopic\u00ae)","volume":"14","author":"Kapp A","year":"2003","unstructured":"Kapp A, Allen BR, Reitamo S. Atopic dermatitis management with tacrolimus ointment (Protopic\u00ae). J Dermatolog Treat. 2003, 14:5-16. 10.1080\/09546634.2003.11864618","journal-title":"J Dermatolog Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109812","article-title":"Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children","volume":"44","author":"Kang S","year":"2001","unstructured":"Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol. 2001, 44:S58-64. 10.1067\/mjd.2001.109812","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M278","article-title":"Association between exposure to topical tacrolimus or pimecrolimus and cancers","volume":"43","author":"Hui RL","year":"2009","unstructured":"Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M. Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother. 2009, 43:1956-63. 10.1345\/aph.1M278","journal-title":"Ann Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10363.x","article-title":"Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors","volume":"165","author":"Tennis P","year":"2011","unstructured":"Tennis P, Gelfand JM, Rothman KJ. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol. 2011, 165:465-73. 10.1111\/j.1365-2133.2011.10363.x","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224261-tacrolimus-ointment-in-periorbital-atopic-dermatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:30Z","timestamp":1707509610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224261-tacrolimus-ointment-in-periorbital-atopic-dermatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.53055","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,27]]}}}